Xeljanz XR 11 mg

Xeljanz XR 11 mg is an extended-release tablet containing tofacitinib citrate, used for managing certain inflammatory conditions. This medication is designed for oral administration and is manufactured by Pfizer Canada ULC.

Xeljanz XR 11 mg is primarily used for the treatment of moderate to severe rheumatoid arthritis in adults who have not responded well to other medications. It works by reducing inflammation and immune system activity. This drug may also be prescribed for other inflammatory conditions as determined by a healthcare provider.

Common effects of Xeljanz XR 11 mg may include headache, diarrhea, and upper respiratory tract infections. Some users might experience nausea or changes in blood cell counts. It's important to monitor for any unusual symptoms and consult a healthcare provider if they persist or worsen.

Xeljanz XR 11 mg should be handled with care, especially for individuals with a history of infections, blood clots, or liver problems. Regular blood tests may be recommended to monitor for potential side effects. Always follow the advice of a healthcare provider regarding the use of this medication.

Xeljanz XR 11 mg may interact with other medications, including those that suppress the immune system or affect liver enzymes. It's important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol should be consumed with caution while using this medication.